Posted on August 19th, 2010 by Health News
Alzheimer’s disease destroys brain cells and their connections (called synapses), causing memory loss and other cognitive problems that disrupt work, hobbies and daily life. Symptoms can be alleviated, in part, by the drug memantine (marketed in the United States as Namenda), which is currently FDA-approved to treat moderate-to-severe Alzheimer’s disease and was, in part, developed [...]
No Comments »
Filed under: Pharmacy News
Posted on August 13th, 2010 by Health News
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
Posted on August 13th, 2010 by Health News
The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug’s manufacturer, GlaxoSmithKline, to update the prescribing [...]
No Comments »
Filed under: Pharmacy News
Posted on August 13th, 2010 by Health News
Primary dysmenorrhea (PDM), or menstrual cramps, is the most common gynecological disorder in women of childbearing age. Lower abdominal pain starts with the onset of menstrual flow and this ongoing pain stimulus can cause alterations throughout the nervous system…
No Comments »
Filed under: Women's Health
Posted on August 11th, 2010 by Health News
Primary dysmenorrheal (PDM), also known as menstrual cramps or period pains, can cause abnormal changes in brain structure, a study published in the medical journal Pain reveals. PDM is the most common gynecological disorder in women of childbearing age…
No Comments »
Filed under: Women's Health
Posted on August 9th, 2010 by Health News
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company’s clinical-stage drug candidate that has disease-modifying potential for Alzheimer’s and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that [...]
No Comments »
Filed under: Pharmacy News
Posted on August 7th, 2010 by Health News
Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson’s antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. [...]
No Comments »
Filed under: Pharmacy News
Posted on August 7th, 2010 by Health News
Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.
No Comments »
Filed under: Pharmacy News
Posted on August 4th, 2010 by Health News
Northwest Biotherapeutics, Inc. today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme (”GBM”), the most rapid and lethal type of brain cancer, were treated with NWBT’s DCVax®-Brain personalized immune therapy.
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2010 by Health News
Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women…
No Comments »
Filed under: Women's Health
